GNTA NASDAQ
Genenta Science S.p.A.
1W: +1.7%
1M: -11.1%
3M: -30.2%
YTD: -55.8%
1Y: -85.3%
3Y: -89.6%
$0.62
-0.01 (-1.35%)
Weekly Expected Move ±8.1%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$11.9M
52W Range0.55-10
Volume24,174
Avg Volume75,132
Beta0.73
Dividend—
Analyst Ratings
Company Info
CEOPierluigi Paracchi
Employees13
SectorHealthcare
IndustryBiotechnology
IPO Date2021-12-15
Websitegenenta.com
Via Olgettina No. 58
Milan, MI 20132
IT
Milan, MI 20132
IT
39 02 26 43 46 81
About Genenta Science S.p.A.
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. The company was incorporated in 2014 and is headquartered in Milan, Italy.
Latest News
Genenta to buy majority stake in aerospace parts maker for €6M
Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs
12 Health Care Stocks Moving In Wednesday's After-Market Session
Genenta, Evolving into Saentra Forge, Announces CEO's Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University
Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Paracchi Pierluigi | A-Award | 100,000 | $0.63 | 2026-03-30 |
| Galimi Francesco | A-Award | 20,000 | $0.63 | 2026-03-30 |
| PARACCHI GIACOMOANTO | A-Award | 20,000 | $0.63 | 2026-03-30 |
| Sharei Armon | A-Award | 20,000 | $0.63 | 2026-03-30 |
| Mutti Miguel Maria | A-Award | 20,000 | $0.63 | 2026-03-30 |